Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Net Margin (2021 - 2025)

Kezar Life Sciences' Net Margin history spans 5 years, with the latest figure at 4537.75% for Q2 2025.

  • For Q2 2025, Net Margin fell 83557.0% year-over-year to 4537.75%; the TTM value through Sep 2025 reached 5892.77%, down 606453.0%, while the annual FY2023 figure was 1455.29%, N/A changed from the prior year.
  • Net Margin for Q2 2025 was 4537.75% at Kezar Life Sciences, down from 4771.18% in the prior quarter.
  • Across five years, Net Margin topped out at 8938.36% in Q4 2021 and bottomed at 330.04% in Q3 2023.
  • The 5-year median for Net Margin is 5585.8% (2022), against an average of 5352.74%.
  • The largest YoY upside for Net Margin was 36266bps in 2023 against a maximum downside of -608714bps in 2023.
  • A 5-year view of Net Margin shows it stood at 8938.36% in 2021, then crashed by -36bps to 5757.1% in 2022, then tumbled by -106bps to 330.04% in 2023, then skyrocketed by 1675bps to 5197.43% in 2024, then dropped by -13bps to 4537.75% in 2025.
  • Per Business Quant, the three most recent readings for KZR's Net Margin are 4537.75% (Q2 2025), 4771.18% (Q1 2025), and 5197.43% (Q4 2024).